Cann Group faces more questions after reporting a bank balance of -$18,000 by Steve Jones October 23, 2024October 23, 2024 Cann Group revenue fell sharply in the first quarter of FY25 as the company continues to […]
Cann Group goes back to investors in bid to raise $6.25m for product expansion by Steve Jones October 8, 2024October 8, 2024
Cann Group cites positive press coverage as possible reason for share price surge by Martin Lane September 30, 2024September 30, 2024
Company news: Cann Group; Helius Therapeutics/Novachem; Elixinol/HFA by Martin Lane September 4, 2024September 5, 2024
Cann Group considers capital raise and Mildura sale and leaseback as financial juggling act goes on by Steve Jones July 31, 2024July 31, 2024
Cann Group outlines ‘investment opportunity’ with four-year growth plan and Mildura expansion by Steve Jones July 25, 2024July 25, 2024
Cann Group confirms Jenni Pilcher as MD and CEO after drawing up ‘well-defined strategy’ by Steve Jones July 18, 2024July 18, 2024